SEC Comment Letter for Zomedica Corp. (ZOM) (CIK 0001684144) (ZOMDF) — Oct 16, 2024

Zomedica Corp. (ZOM) (CIK 0001684144)
Date: Oct. 16, 2024 · CIK: 0001684144 · Accession: 0000000000-24-011649

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 001-38298

Date

October 16, 2024

Author

Michael Zuehlke

Form

UPLOAD

Company

Zomedica Corp. (ZOM) (CIK 0001684144)

Letter

October 16, 2024 Michael Zuehlke Vice President of Finance and Corporate Controller Zomedica Corp. 100 Phoenix Drive, Suite 125 Ann Arbor, Michigan 48108 Re:Zomedica Corp. Form 10-K for Fiscal Year Ended December 31, 2023 File No. 001-38298 Dear Michael Zuehlke: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences

Show Raw Text

October 16, 2024
Michael Zuehlke
Vice President of Finance and Corporate Controller
Zomedica Corp.
100 Phoenix Drive, Suite 125
Ann Arbor, Michigan 48108
Re:Zomedica Corp.
Form 10-K for Fiscal Year Ended December 31, 2023
File No. 001-38298
Dear Michael Zuehlke:
            We have completed our review of your filings. We remind you that the company and
its management are responsible for the accuracy and adequacy of their disclosures,
notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences

SecProbe.io